{
    "2020-10-19": [
        [
            {
                "time": "2021-11-15",
                "original_text": "Pfizer: The Pace of COVID-19 Vaccine Development Is Remarkable, Says Analyst",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "COVID-19",
                        "vaccine",
                        "development",
                        "analyst"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Pfizer (PFE) Stock Moves -0.4%: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock",
                        "moves",
                        "-0.4%"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "‘The most difficult phase of the epidemic is ahead of us’ : doctor",
                "features": {
                    "keywords": [
                        "epidemic",
                        "difficult",
                        "phase",
                        "doctor"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Bristol Myers Squibb, Exelixis Granted FDA Priority Review For Kidney Cancer Treatment",
                "features": {
                    "keywords": [
                        "Bristol Myers Squibb",
                        "Exelixis",
                        "FDA",
                        "priority review",
                        "kidney cancer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Dow Jones Today, Stocks Rise On Stimulus Hope, China Data; Conoco To Buy Concho; Getting A Handle On Apple's Base",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "stocks",
                        "rise",
                        "stimulus hope",
                        "China data",
                        "Conoco",
                        "Concho",
                        "Apple"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}